Skip to main
FNCH
FNCH logo

Finch Therapeutics Group (FNCH)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy FNCH Stock

About Finch Therapeutics Group (FNCH)

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Market cap$21.2M
Today's volume17
Revenue (TTM)
Avg. daily volume1.81K
EBITDA (TTM)-$19.51M
Open$13
Price / earnings ratio-1.50x
Today's range$12.89 - $13.2
Debt / equity203.88x
52 week range$1.27 - $15.85
5 year debt / equity42.69x
Beta (LTM)-0.07x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio3.87x
Ex-dividend date
Next earningsAug 12, 2025
Dividend payable date

FNCH Stock Rating

What analysts recommend for FNCH stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 30, 2025, the market cap for FNCH stock is $21.2M

The current P/E ratio for FNCH stock is -1.5

The 52-week high for FNCH stock is $15.85. The current FNCH stock price $undefined is 100.00% below its 52-week high

The 52-week low for FNCH stock is $1.27. The current FNCH stock price $undefined has increased 100.00% from its 52-week low

No, the FNCH stock does not pay dividends to its shareholders

The target price for FNCH stock is $20.75 based on the average of what a group of analyst think FNCH stock could be worth at a future date. This is not a prediction by Public.com

How to buy FNCH stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in FNCH stock

    Navigate to the Explore page. Then, type FNCH into the search bar. When you see FNCH stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased FNCH stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Finch Therapeutics Group Stock Earnings

The value each FNCH share was expected to gain vs. the value that each FNCH share actually gained.

FNCH (FNCH) reported Q4 2022 earnings per share (EPS) of -$16.80, missing estimates of -$10.20 by 64.71%. In the same quarter last year, FNCH's earnings per share (EPS) was -$12. FNCH is expected to release next earnings on 08/12/2025, with an earnings per share (EPS) estimate of $0.

Buy FNCH Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.